Physician profile
Jonathan D Witzke
NPI 1093838617
$872.54
in general payments reported to CMS, 2019-2025
11 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.95 · 2022: $199 · 2023: $266 · 2024: $173 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $645.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $435.98 | 2022-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Acera Surgical, INC. | $157.92 | 2025 | Restrata Wound Matrix |
| Musculoskeletal Transplant Foundation INC. | $73.27 | 2024-2025 | |
| Mentor Worldwide LLC | $41.50 | 2022 | |
| Avanos Medical | $39.02 | 2023-2024 | On-Q* Pump and Accessories |
| Innovation Technologies INC | $31.39 | 2023 | Irrisept |
| Depuy Synthes Sales INC. | $27.95 | 2021 | |
| Sientra, INC. | $23.02 | 2022 | |
| Abbvie INC. | $15.06 | 2025 | |
| Davol INC. | $13.91 | 2025 | Arista |
| Mesh Suture INC | $13.52 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Witzke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.